Guardant Health
GH
#2538
Rank
ยฃ4.25 B
Marketcap
ยฃ34.51
Share price
-3.29%
Change (1 day)
146.33%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Cash on Hand

Cash on Hand as of December 2024 : ยฃ0.64 Billion

According to Guardant Health 's latest financial reports the company has ยฃ0.64 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Guardant Health - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31ยฃ0.66 B-27.03%
2023-12-31ยฃ0.91 B9.74%
2022-12-31ยฃ0.83 B20.96%
2021-12-31ยฃ0.69 B-47.52%
2020-12-31ยฃ1.31 B230.28%
2019-12-31ยฃ0.39 B20.79%
2018-12-31ยฃ0.33 B101.55%
2017-12-31ยฃ0.16 B112.13%
2016-12-31ยฃ77.19 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
ยฃ0.74 B 15.27%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.10 B-83.31%๐Ÿ‡บ๐Ÿ‡ธ USA